RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company ...

Goldman Sachs reiterated its Buy rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares with a steady price target of $78.00. The firm's analyst highlighted Ultragenyx's fourth-quarter total ...

State of Alaska Department of Revenue cut its position in Fortune Brands Innovations, Inc. (NYSE:FBIN – Free Report) by 1.8% during the fourth quarter, according to the company in its most recent ...

DoorDash (NASDAQ:DASH – Get Free Report) had its price target raised by stock analysts at The Goldman Sachs Group from $192.00 to $212.00 in a research note issued on Wednesday,Benzinga reports. The ...

Goldman Sachs has raised the upside potential for European stocks on rising odds of peace in Ukraine. "For European equities ...

RBC Capital analyst Gordon Ramsay CFA maintained a Buy rating on Origin Energy Limited (OGFGF – Research Report) yesterday and set a price ...

markets rebounded and he slimmed down Goldman's retail operations. Goldman Sachs shares rose almost 2% on Friday afternoon. The bank's share price jumped 48% in the last year, and is up 174 ...

SailPoint, Inc. ("SailPoint"), a leader in unified identity security for enterprises, today announced the pricing of its upsized initial public offering of 60,000,000 shares of its common stock at a ...

A weak vaccine result dragged on CSL's H1 result but analysts focus on an improving plasma product margin and solid growth ...

Macquarie Group has withdrawn from the world’s largest climate banking alliance, making it the first major Australian ...

Goldman Sachs would consider acquisitions in asset and wealth management, but would be highly selective about any deal, CEO ...

Goldman Sachs will drop a demand that corporate boards of directors include women and members of minority groups as financial ...